Inventage Lab has the technology to mass-produce micro/nano drug delivery systems using microfluidics technology. Sustained-release injectables using polymeric microspheres have been commercialized, and lipid nano delivery systems such as liposome and LNP are now being manufactured.
| Website | http://www.inventagelab.com |
| Revenue | $5.1 million |
| Employees | 27 (19 on RocketReach) |
| Founded | 2015 |
| Address | 12 Yanghyeong-ro 405 beon-gil, Seongnam-si, Gyeonggi-do, KR |
| Phone | +1 0316080514 |
| Technologies |
JavaScript
,
Nginx
,
Microsoft Outlook
+1 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Biopharma, Drug Delivery, Biotechnology, Other Pharmaceuticals and Biotechnology, Health Care, Science and Engineering, Medical |
| Keywords | Drug Delivery Systems, Nanomedicine, Microfluidics, Nanotechnology, Drug Formulation, Microspheres, Liposomes, Sustained Release, Targeted Drug Delivery, Injectables, Controlled Release, Microfluidic Devices, Precision Medicine, Pharmaceutical Technology, Pharmaceutical Research, Biotechnology, Biomedical Engineering, Mass Production |
| Competitors | Techstars, Appen, Y Combinator, uTest, UserTesting, Indiegogo, Designlab, LaunchPad Lab, BetaTesting, VentureLab +34 more (view full list) |
Looking for a particular Inventage Lab employee's phone or email?
The Inventage Lab annual revenue was $5.1 million in 2026.
Juhee Kim is the CEO of Inventage Lab.
19 people are employed at Inventage Lab.
Inventage Lab is based in Seongnam-si, Gyeonggi-do.